Wakunaga Pharmaceutical Co., Ltd.   Report issue

For profit Phase 2 Phase 4
Founded: Osaka Japan (1955)
Status: No NME R&D (1955)

Organization Overview

First Clinical Trial
2008
NCT00578799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Wakunga of America Co. Ltd.